CTXR - Citius Pharmaceuticals, Inc.

QQQ $ 604.27 $ -5.89 (-0.96 %)

DIA $ 464.98 $ -3.44 (-0.73 %)

SPY $ 666.76 $ -3.49 (-0.52 %)

TLT $ 92.19 $ 0.06 (0.07 %)

GLD $ 376.01 $ 0.04 (0.01 %)

Previous Close

$ 1.57

Open

$ 1.69

Bid

$ 1.50 x 1,000

Ask

$ 1.84 x 374

Day's Range

-- - --

52 Week Range

$ 0.65 - $ 12.84

Volume

1,075,261

Average Volume

Market Cap

Beta (5Y Monthly)

$ 1.27

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	02-14-2025	12-31-2024	10-Q
4	12-27-2024	09-30-2024	10-K
5	08-12-2024	06-30-2024	10-Q
6	05-14-2024	03-31-2024	10-Q
7	02-14-2024	12-31-2023	10-Q
8	12-29-2023	09-30-2023	10-K
9	08-14-2023	06-30-2023	10-Q
10	05-12-2023	03-31-2023	10-Q
11	02-10-2023	12-31-2022	10-Q
12	12-22-2022	09-30-2022	10-K
13	08-11-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	02-10-2022	12-31-2021	10-Q
16	12-15-2021	09-30-2021	10-K
17	08-12-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	02-11-2021	12-31-2020	10-Q
20	12-16-2020	09-30-2020	10-K
21	08-14-2020	06-30-2020	10-Q
22	05-14-2020	03-31-2020	10-Q
23	02-13-2020	12-31-2019	10-Q
24	12-16-2019	09-30-2019	10-K
25	08-14-2019	06-30-2019	10-Q
26	05-15-2019	03-31-2019	10-Q
27	02-14-2019	12-31-2018	10-Q
28	12-11-2018	09-30-2018	10-K
29	08-14-2018	06-30-2018	10-Q
30	05-11-2018	03-31-2018	10-Q
31	02-14-2018	12-31-2017	10-Q
32	12-13-2017	09-30-2017	10-K
33	08-14-2017	06-30-2017	10-Q
34	05-15-2017	03-31-2017	10-Q
35	02-14-2017	12-31-2016	10-Q
36	12-23-2016	09-30-2016	10-K
37	08-15-2016	06-30-2016	10-Q
38	05-20-2016	03-31-2016	10-Q
39	02-12-2016	12-31-2015	10-Q
40	12-14-2015	09-30-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

paccar-posts-downbeat-earnings-joins-neuphoria-therapeutics-citius-pharmaceuticals-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

PACCAR Posts Downbeat Earnings, Joins Neup...
10/21/2025 12:16:10

12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 12:10:04

Citius Pharmaceuticals Announces $6M Citiu...
10/21/2025 12:04:23

Citius Oncology Secures McKesson As Author...
10/20/2025 12:39:56

McKesson joins leading distribution service providers as authorized U.S. distributor of LYMPHIRCRANFORD, N.J., Oct. 20, 2025 /P...

Citius Oncology Announced It Has Finalized...
10/16/2025 12:52:03

EVERSANA to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated Cutan...

12 Health Care Stocks Moving In Friday's P...
09/19/2025 12:09:04

Citius Oncology To Raise $9M In Registered...
09/09/2025 12:47:28

Citius Oncology, Inc. ("Citius Oncology") (NASDAQ:CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc...

Citius Oncology Deploys AI Platform To Bol...
08/22/2025 12:49:42

Proprietary model informs targeted sales and marketing strategies with feedback loop thataugments precision and impact of targe...

D. Boral Capital Maintains Buy on Citius P...
08/13/2025 16:16:00

D. Boral Capital analyst Jason Kolbert maintains Citius Pharmaceuticals (NASDAQ:CTXR) with a Buy and maintains $6 price target.

Citius Pharma Q3 EPS $(0.80) Misses $(0.58...
08/12/2025 20:33:15

Citius Pharma (NASDAQ:CTXR) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.5...

Citius Oncology Announces Pricing Of $9M "...
07/16/2025 13:17:30

Citius Oncology, Inc. ("Citius Oncology" or the "Company") (NASDAQ:CTOR), a majority-owned subsidiary of Citius...

Citius Oncology Partners With Cencora To B...
07/15/2025 12:35:42

Agreement with global pharmaceutical solutions provider enhances commercial infrastructure and reinforces launch readiness for ...

Citius Pharmaceuticals Regains Compliance ...
07/08/2025 12:37:56

D. Boral Capital Maintains Buy on Citius P...
06/30/2025 11:24:18

D. Boral Capital analyst Jason Kolbert maintains Citius Pharmaceuticals (NASDAQ:CTXR) with a Buy and maintains $6 price target.

12 Health Care Stocks Moving In Friday's I...
06/27/2025 17:05:50

12 Health Care Stocks Moving In Tuesday's ...
06/24/2025 21:06:13

12 Health Care Stocks Moving In Friday's A...
06/20/2025 21:05:49

Citius Oncology Sees Commercial Launch Of ...
06/17/2025 12:09:35

12 Health Care Stocks Moving In Tuesday's ...
06/10/2025 17:06:51

citius-pharmaceuticals-stock-is-falling-tuesday-whats-going-on

Citius Pharmaceuticals Stock Is Falling Tu...
06/10/2025 15:09:19

Citius announced a $15.8 million direct offering.